Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Fabio Parisi

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 26, 2022
Reply to Schriever et alGiuseppe Fabio Parisi, Michele Miraglia Del Giudice
BMJ Case Reports|May 30, 2019
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheatFederica Sullo, Giuseppe Fabio Parisi, Annarita Bongiovanni, et al.
Journal of Clinical Medicine|August 12, 2022
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old DiseaseSara Manti, Alessandro Giallongo, Maria Papale, et al.
Journal of Clinical Medicine|November 27, 2025
Treatable Traits in Pediatric Interstitial Lung Diseases: Bridging the Gap to Tailored TherapeuticsGiuseppe Fabio Parisi, Maria Papale, Giulia Pecora, et al.
Frontiers in Pediatrics|December 31, 2020
COVID-19 Pneumonia in Children: From Etiology to ManagementGiuseppe Fabio Parisi, Cristiana Indolfi, Fabio Decimo, et al.
Viruses|September 28, 2023
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-PandemicSantiago Presti, Sara Manti, Francesco Gambilonghi, et al.
Children (Basel, Switzerland)|November 24, 2022
Interstitial Lung Disease in Children: "Specific Conditions of Undefined Etiology" Becoming ClearerSantiago Presti, Giuseppe Fabio Parisi, Maria Papale, et al.
Immunity, Inflammation and Disease|January 12, 2021
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature reviewSara Manti, Giuseppe Fabio Parisi, Maria Papale, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 26, 2022
Type 2 inflammation in cystic fibrosis: New insightsSara Manti, Giuseppe Fabio Parisi, Maria Papale, et al.
Biomedicines|March 28, 2025
Severe Asthma and Active SARS-CoV-2 Infection: Insights into BiologicsSara Manti, Michela Leotta, Federica D'Amico, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 26, 2022
Reply to Schriever et alGiuseppe Fabio Parisi, Michele Miraglia Del Giudice
BMJ Case Reports|May 30, 2019
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheatFederica Sullo, Giuseppe Fabio Parisi, Annarita Bongiovanni, et al.
Journal of Clinical Medicine|August 12, 2022
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old DiseaseSara Manti, Alessandro Giallongo, Maria Papale, et al.
Journal of Clinical Medicine|November 27, 2025
Treatable Traits in Pediatric Interstitial Lung Diseases: Bridging the Gap to Tailored TherapeuticsGiuseppe Fabio Parisi, Maria Papale, Giulia Pecora, et al.
Frontiers in Pediatrics|December 31, 2020
COVID-19 Pneumonia in Children: From Etiology to ManagementGiuseppe Fabio Parisi, Cristiana Indolfi, Fabio Decimo, et al.
Viruses|September 28, 2023
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-PandemicSantiago Presti, Sara Manti, Francesco Gambilonghi, et al.
Children (Basel, Switzerland)|November 24, 2022
Interstitial Lung Disease in Children: "Specific Conditions of Undefined Etiology" Becoming ClearerSantiago Presti, Giuseppe Fabio Parisi, Maria Papale, et al.
Immunity, Inflammation and Disease|January 12, 2021
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature reviewSara Manti, Giuseppe Fabio Parisi, Maria Papale, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 26, 2022
Type 2 inflammation in cystic fibrosis: New insightsSara Manti, Giuseppe Fabio Parisi, Maria Papale, et al.
Biomedicines|March 28, 2025
Severe Asthma and Active SARS-CoV-2 Infection: Insights into BiologicsSara Manti, Michela Leotta, Federica D'Amico, et al.
Pageof 7